On December 4-8th, 2020, the American Epilepsy Society (AES) held its annual conference to bring together clinicians and scientists on the cutting edge of epilepsy research. This year had a multitude of presentations related to Dravet syndrome, making for an exciting few days focused on what we have learned about Dravet syndrome through research and where the field is going next.
The conversations kicked off the night before the meeting at the Dravet Syndrome Foundation’s (DSF) Research Roundtable, which the largest Roundtable meeting to date. We heard presentations from several past DSF grant awardees along with other experts in the field. DSF also announced the three new 2020 Grant awardees at the Roundtable, bringing DSF’s total funding for research to almost $5M. You can read more about the Research Roundtable here.
The following several days at the AES meeting were full of discussions and presentations surrounding many topics in Dravet syndrome including: new medications and treatments, expanding our understanding of the genetic contributors, parsing out the cell types in the brain that are affected, SUDEP, and topics relevant to Dravet syndrome in adults. If you are interested in reading more about what was discussed at AES 2020, DSF’s research coordinator, Dr. Veronica Hood, wrote a blog post detailing some of the most relevant presentations. You can find the blog post here.